Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Core EBITDA Growth

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 18.3121.3829.11-12.9944.86

What is the latest Core EBITDA Growth ratio of CONCORD BIOTECH ?

The latest Core EBITDA Growth ratio of CONCORD BIOTECH is 18.31 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202518.31
Mar202421.38
Mar202329.11
Mar2022-12.99
Mar202144.86

How is Core EBITDA Growth of CONCORD BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2025 18.31
-14.36
Mar2024 21.38
-26.55
Mar2023 29.11
Positive
Mar2022 -12.99
Negative
Mar2021 44.86 -

Other Financial Ratios of CONCORD BIOTECH


Compare Core EBITDA Growth ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹12,204.7 Cr 2.5% 2.3% -30.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,469.0 Cr -2.8% -1% 6.7% Stock Analytics
DIVIS LABORATORIES ₹173,305.0 Cr -3.3% 0.4% -2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,014.0 Cr -3.1% 2.9% 36.9% Stock Analytics
CIPLA ₹111,388.0 Cr -2.7% 5.3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,381.0 Cr -4.1% -3.7% 3.7% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

2.5%

2.3%

-30.8%

SENSEX

-2.4%

-3.7%

-9.2%


You may also like the below Video Courses